Squamous Cell Carcinoma: Restaging and Response to Therapy.
Publication
, Journal Article
Subramaniam, RM; Lowe, VJ
Published in: PET clinics
October 2007
This article describes the use of 18F-fluorodeoxyglucose PET in patients who have head and neck cancer for assessment of therapy response, detection of locoregional recurrence and distant metastasis, and surveillance.
Duke Scholars
Published In
PET clinics
DOI
EISSN
1879-9809
ISSN
1556-8598
Publication Date
October 2007
Volume
2
Issue
4
Start / End Page
481 / 487
Related Subject Headings
- Nuclear Medicine & Medical Imaging
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Subramaniam, R. M., & Lowe, V. J. (2007). Squamous Cell Carcinoma: Restaging and Response to Therapy. PET Clinics, 2(4), 481–487. https://doi.org/10.1016/j.cpet.2008.05.008
Subramaniam, Rathan M., and Val J. Lowe. “Squamous Cell Carcinoma: Restaging and Response to Therapy.” PET Clinics 2, no. 4 (October 2007): 481–87. https://doi.org/10.1016/j.cpet.2008.05.008.
Subramaniam RM, Lowe VJ. Squamous Cell Carcinoma: Restaging and Response to Therapy. PET clinics. 2007 Oct;2(4):481–7.
Subramaniam, Rathan M., and Val J. Lowe. “Squamous Cell Carcinoma: Restaging and Response to Therapy.” PET Clinics, vol. 2, no. 4, Oct. 2007, pp. 481–87. Epmc, doi:10.1016/j.cpet.2008.05.008.
Subramaniam RM, Lowe VJ. Squamous Cell Carcinoma: Restaging and Response to Therapy. PET clinics. 2007 Oct;2(4):481–487.
Published In
PET clinics
DOI
EISSN
1879-9809
ISSN
1556-8598
Publication Date
October 2007
Volume
2
Issue
4
Start / End Page
481 / 487
Related Subject Headings
- Nuclear Medicine & Medical Imaging
- 3211 Oncology and carcinogenesis